CN112930200A - 用于视网膜神经节细胞中特异表达基因的启动子SynP151(ProC29) - Google Patents

用于视网膜神经节细胞中特异表达基因的启动子SynP151(ProC29) Download PDF

Info

Publication number
CN112930200A
CN112930200A CN201980069414.0A CN201980069414A CN112930200A CN 112930200 A CN112930200 A CN 112930200A CN 201980069414 A CN201980069414 A CN 201980069414A CN 112930200 A CN112930200 A CN 112930200A
Authority
CN
China
Prior art keywords
nucleic acid
cell
gene
retinal ganglion
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980069414.0A
Other languages
English (en)
Chinese (zh)
Inventor
J·于特纳
J·科洛尔
B·罗斯卡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research
Original Assignee
Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research filed Critical Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research
Publication of CN112930200A publication Critical patent/CN112930200A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN201980069414.0A 2018-10-25 2019-10-24 用于视网膜神经节细胞中特异表达基因的启动子SynP151(ProC29) Pending CN112930200A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18202538.7 2018-10-25
EP18202538 2018-10-25
PCT/IB2019/059092 WO2020084541A1 (en) 2018-10-25 2019-10-24 Synp151 (proc29), a promoter for the specific expression of genes in retinal ganglion cells

Publications (1)

Publication Number Publication Date
CN112930200A true CN112930200A (zh) 2021-06-08

Family

ID=63998567

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980069414.0A Pending CN112930200A (zh) 2018-10-25 2019-10-24 用于视网膜神经节细胞中特异表达基因的启动子SynP151(ProC29)

Country Status (5)

Country Link
US (1) US20210388387A1 (https=)
EP (1) EP3870242A1 (https=)
JP (1) JP2022505517A (https=)
CN (1) CN112930200A (https=)
WO (1) WO2020084541A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010011467A (es) 2008-04-18 2011-02-15 Novartis Forschungsstiftung Novedosas herramientas y metodos terapeuticos para tratar la ceguera.
US10941417B2 (en) 2015-04-30 2021-03-09 Friedrich Miescher Institute For Biomedical Research Promoter for the specific expression of genes in Müller cells
US10857241B2 (en) 2015-09-15 2020-12-08 Friedrich Miescher Institute For Biomedical Research Therapeutical tools and methods for treating blindness by targeting photoreceptors
WO2017064642A1 (en) 2015-10-14 2017-04-20 Fredrich Miescher Institute For Biomedical Research Promoter for the specific expression of genes in retinal endothelial cells
EP3383440B1 (en) 2015-12-03 2021-06-30 Friedrich Miescher Institute for Biomedical Research Synp162, a promoter for the specific expression of genes in rod photoreceptors
ES2909444T3 (es) 2015-12-03 2022-05-06 Friedrich Miescher Institute For Biomedical Res Synp159, un promotor para la expresión específica de genes en los fotorreceptores de los bastones
WO2017093934A1 (en) 2015-12-03 2017-06-08 Friedrich Miescher Institute For Biomedical Research Synp160, a promoter for the specific expression of genes in rod photoreceptors
EP3383439B1 (en) 2015-12-03 2019-09-25 Friedrich Miescher Institute for Biomedical Research Synp161, a promoter for the specific expression of genes in rod photoreceptors
RU2766353C2 (ru) 2016-11-02 2022-03-15 Фридрих Мишер Инститьют Фор Байомедикал Рисерч Synp198, промотор для специфической экспрессии генов в ганглионарных клетках сетчатки, избирательных в отношении направления
WO2018146588A1 (en) 2017-02-08 2018-08-16 Friedrich Miescher Institute For Biomedical Research Synp88, a promoter for the specific expression of genes in retinal ganglion cells
MX2020005033A (es) 2017-11-15 2020-10-28 Friedrich Miescher Institute For Biomedical Res Promotor especifico de las celulas del epitelio pigmentario retinal en primates.
SG11202005024QA (en) 2017-11-30 2020-06-29 Friedrich Miescher Institute For Biomedical Res Synpiii, a promoter for the specific expression of genes in retinal pigment epithelium

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108350463A (zh) * 2015-09-15 2018-07-31 弗里德里克·米谢尔生物医学研究所 通过靶向光受体治疗失明的新型治疗工具和方法
CN108472389A (zh) * 2015-12-03 2018-08-31 弗里德里克·米谢尔生物医学研究所 SynP161，用于基因在视杆光感受器中特异性表达的启动子

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3007730A1 (en) * 2013-06-11 2016-04-20 Friedrich Miescher Institute for Biomedical Research Retinal on bipolar cells-specific artificial promoter
RU2766353C2 (ru) * 2016-11-02 2022-03-15 Фридрих Мишер Инститьют Фор Байомедикал Рисерч Synp198, промотор для специфической экспрессии генов в ганглионарных клетках сетчатки, избирательных в отношении направления

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108350463A (zh) * 2015-09-15 2018-07-31 弗里德里克·米谢尔生物医学研究所 通过靶向光受体治疗失明的新型治疗工具和方法
CN108472389A (zh) * 2015-12-03 2018-08-31 弗里德里克·米谢尔生物医学研究所 SynP161，用于基因在视杆光感受器中特异性表达的启动子

Also Published As

Publication number Publication date
WO2020084541A1 (en) 2020-04-30
JP2022505517A (ja) 2022-01-14
EP3870242A1 (en) 2021-09-01
US20210388387A1 (en) 2021-12-16

Similar Documents

Publication Publication Date Title
US20220267800A1 (en) Synp88, a promoter for the expression of genes
CN111726985B (zh) 灵长类动物视网膜色素上皮细胞特异性启动子
CN112930200A (zh) 用于视网膜神经节细胞中特异表达基因的启动子SynP151(ProC29)
CN112912111A (zh) 用于视网膜神经节细胞中特异表达基因的启动子SynP17(ProB1)
CN112930201A (zh) 用于视网膜神经节细胞中特异表达基因的启动子SynP78(ProA27)
CN108472389B (zh) SynP161，用于基因在视杆光感受器中特异性表达的启动子
CN113316643A (zh) 用于使基因在视网膜神经节细胞中特异性表达的启动子SynP35(ProC8)
CN112912508A (zh) 用于使基因在视网膜神经节细胞中特异性表达的启动子SynP194(ProB15)
RU2766353C2 (ru) Synp198, промотор для специфической экспрессии генов в ганглионарных клетках сетчатки, избирательных в отношении направления
US20220119841A1 (en) Synp5 (proa9), a promoter for the specific expression of genes in retinal ganglion cells
US20220090062A1 (en) Synp66 (proa21), a promoter for the specific expression of genes in retinal ganglion cells
US20210388386A1 (en) Synp57 (proa14), a promoter for the specific expression of genes in photoreceptors
CN108472390B (zh) SynP162,用于基因在视杆光感受器中特异性表达的启动子
CN111542611A (zh) 用于使基因在视网膜色素上皮中特异性表达的启动子SynPIII
WO2020152626A1 (en) Synp166 (proa36), a promoter for the specific expression of genes in photoreceptors
CN111527102A (zh) 灵长类动物视网膜色素上皮细胞特异性启动子SynP61

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20210608

WD01 Invention patent application deemed withdrawn after publication